Please select the option that best describes you:
Is there a potential role for GLP-1 receptor agonists in the management of premenstrual dysphoric disorder?
Have you considered these agents in treatment-resistant cases or in patients with comorbid metabolic conditions?
Answer from: at Community Practice
This is an interesting question! I don't think we have enough information yet to answer, but I wouldn't be surprised if we find some benefit for PMDD, premenstrual exacerbation of symptoms, and PMS. This might be related to the anti-inflammatory effects of GLP-1 drugs, improved management of diabete...
Sign in or Register to read more